DCOY is Decoy Therapeutics Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.69. Market cap: $2M.
Stock snapshot
| Price | $2.69 |
| Market cap | $2M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About DCOY
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
Related non-dividend companies
Other non-dividend stocks investors research alongside DCOY. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is DCOY's current stock price?
DCOY (Decoy Therapeutics Inc.) is currently trading at $2.69.
Does DCOY pay a dividend?
DCOY (Decoy Therapeutics Inc.) does not currently pay a regular dividend.
Track DCOY in DiviDrip
Add DCOY to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search DCOY and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.